modern
biotechnolog
provid
huge
potenti
human
health
improv
develop
new
therapi
vaccin
infecti
diseas
best
case
vaccin
provid
great
econom
valu
costbenefit
ratio
center
diseas
control
prevent
howev
develop
implement
new
vaccin
often
encount
substanti
cost
logist
barrier
difficult
overcom
mani
countri
econom
depress
use
transgen
plantderiv
recombin
protein
promis
strategi
combin
innov
medic
scienc
plant
biolog
creat
afford
vaccin
potenti
benefit
low
cost
heat
stabil
oral
administr
conveni
product
develop
countri
grow
number
laboratori
invest
plantderiv
protein
pharmaceut
expand
semin
work
first
propos
idea
curti
cardineau
mason
et
al
subject
plantderiv
vaccin
review
sever
time
recent
year
koprowski
yusibov
mason
et
al
nearli
comprehens
list
vaccin
antigen
produc
plant
provid
daniel
et
al
much
research
yet
need
optim
plant
product
vaccin
valid
largescal
clinic
trial
result
date
show
promis
technolog
brink
commerci
develop
ingest
transgen
plant
express
vaccin
antigen
via
gut
lymphoid
system
result
specif
mucos
secretori
iga
siga
serum
igg
antibodi
respons
although
protect
efficaci
plantderiv
vaccin
yet
determin
human
challeng
studi
anim
shown
promis
result
discuss
later
text
previou
chapter
seri
palmer
et
al
describ
plant
express
system
use
vaccin
studi
detail
chapter
examin
advanc
field
transgen
plantderiv
mucos
vaccin
focus
result
human
clinic
trial
oral
deliv
anim
vaccin
anoth
chapter
volum
lomonossoff
gp
see
chapter
describ
work
involv
plant
virus
produc
vaccin
bacteri
diarrhea
enterotoxigen
escherichia
coli
etec
vibrio
cholera
diarrhea
caus
bacteri
viral
infect
caus
sever
dehydr
particularli
danger
children
elderli
especi
develop
countri
infecti
diarrheal
diseas
major
caus
morbid
mortal
estim
diarrhea
caus
million
death
yearli
mostli
age
group
less
year
sever
differ
bacteria
caus
acut
gastroenter
colon
gastrointestin
gi
tract
via
contamin
water
food
capabl
system
infect
cross
mucos
epithelium
septicem
form
other
colon
intestin
tract
secret
toxin
absorb
enterocyt
caus
diarrhea
enterotoxigen
form
two
wide
spread
well
studi
latter
enterotoxigen
e
coli
etec
vibrio
cholera
toxin
produc
labil
toxin
lt
cholera
toxin
ct
respect
similar
primari
sequenc
structur
mechan
action
sixma
et
al
ringshap
pentam
form
five
ident
noncoval
link
b
subunit
respons
bind
g
gangliosid
ct
lt
gangliosid
lt
mucos
epitheli
cell
toxic
subunit
transloc
epitheli
cell
gi
tract
adpribosyl
transferas
activ
promot
efflux
water
electrolyt
ltb
ctb
among
potent
oral
immunogen
known
oral
deliveri
effici
caus
accumul
specif
serum
igg
iga
mucos
siga
antibodi
holmgren
et
al
lt
ct
also
function
mucos
adjuv
stimul
antibodi
product
codeliv
antigen
gangliosidebind
activ
ltb
pentam
requir
mucos
immunogen
adjuvant
holotoxin
guidri
et
al
plant
system
use
express
ltb
ctb
exampl
other
report
express
gangliosidebind
pentamer
ltb
transgen
potato
tobacco
plant
haq
et
al
mice
fed
transgen
tuber
show
product
serum
mucos
antibodi
ltb
later
plantoptim
ltb
gene
synthes
prefer
codon
avoid
spuriou
mrna
process
signal
ultim
result
increas
express
potato
mice
fed
g
transgen
tuber
contain
ltb
interv
week
titer
antiltb
serum
igg
fecal
iga
antibodi
improv
earlier
experimentthes
mice
partial
protect
dose
lt
indic
potenti
efficaci
use
potato
vaccin
human
similar
studi
other
found
ltb
express
corn
eaten
raw
corn
meal
stimul
antibodi
respons
mice
partial
protect
toxin
challeng
preclin
studi
potato
express
ltb
led
first
trial
transgen
plantderiv
vaccin
administ
human
tacket
et
al
fourteen
volunt
ingest
either
g
transgen
potato
g
transgen
potato
g
nontransgen
potato
ltb
content
tuber
vari
per
gram
tuber
weight
dose
given
day
volunt
report
instanc
minor
side
effect
nausea
cramp
diarrhea
raw
potato
welltoler
overal
ten
volunt
ate
potato
express
ltb
none
ate
placebo
potato
develop
least
fourfold
increas
level
toxinneutr
serum
igg
antibodi
ltb
five
volunt
show
least
fourfold
rise
antiltb
iga
detect
stool
samplesthes
data
compar
favor
earlier
studi
volunt
challeng
etec
cell
tacket
et
al
unpublish
studi
signific
first
ever
examin
edibl
plant
vaccin
human
show
great
potenti
new
strategi
ctb
molecul
also
express
transgen
potato
tuber
tsp
arakawa
et
plantproduc
ctb
assembl
pentamer
structur
shown
bind
g
gangliosid
react
specif
antictb
igg
antibodi
mice
immun
fed
raw
potato
tuber
express
ctb
develop
specif
serum
mucos
antibodi
arakawa
et
al
interest
previous
immun
mice
edibl
ctb
abl
trigger
signific
boost
respons
moreov
ctb
produc
plant
heatresist
transgen
potato
tuber
cook
soft
retain
gangliosidebind
activ
norwalk
viru
relat
norwalklik
virus
respons
outbreak
acut
epidem
gastroenter
unit
state
norwalk
viru
capsid
protein
nvcp
antigen
chosen
develop
oral
edibl
vaccin
sinc
express
insect
cell
assembl
norwalk
viruslik
particl
vlp
react
serum
infect
human
jiang
et
al
tobacco
potato
plant
transform
construct
harbor
nvcp
sequenc
plant
recombin
protein
assembl
vlp
ident
insect
cellderiv
antigen
mason
et
al
mice
gavag
partial
purifi
vlp
tobacco
leaf
fed
transgen
tuber
develop
serum
igg
fecal
iga
antibodi
specif
nvcp
clinic
trial
perform
potato
use
preclin
studi
tacket
et
al
adult
volunt
receiv
two
dose
day
receiv
three
dose
day
g
raw
transgen
potato
tuber
contain
nvcp
import
note
tuber
express
quit
variabl
half
nvcp
potato
assembl
vlp
thu
effect
dose
potato
vaccin
unassembl
subunit
like
much
less
stabl
gi
tract
thu
less
immunogen
howev
subject
experiment
group
show
signific
increas
number
iga
antibodyform
cell
afc
rang
per
peripher
blood
mononuclear
cell
pbmc
subject
group
develop
increas
igg
afc
four
volunt
show
increas
serum
igg
antinvcp
antibodi
titer
increas
serum
igm
show
increas
iga
stool
sampl
mean
increas
although
antibodi
respons
less
impress
obtain
ltb
studi
show
plantderiv
protein
ltb
ctb
stimul
human
immun
respons
oral
deliveri
insect
cellderiv
dose
purifi
norwalk
vlp
provid
effect
seroconvers
ball
et
al
thu
like
part
potatodeliv
nvcp
unavail
uptak
gi
tract
recent
studi
transgen
tomato
fruit
plantoptim
nvcp
gene
result
higher
express
potent
immun
respons
mice
fed
freezedri
tomato
x
zhang
hs
mason
unpublish
result
clinic
trial
plan
dri
tomato
powder
formul
gelatin
capsul
use
evalu
safeti
immunogen
kirk
hs
mason
cj
arntzen
trial
investig
world
health
organ
estim
approxim
million
chronic
carrier
hepat
b
viru
hbv
infect
hbv
lead
liver
cancer
result
mani
million
death
annual
transmiss
hbv
primarili
blood
andor
sexual
contact
also
high
incid
motherchild
transmiss
childbirth
thu
vaccin
provid
mucos
immun
protect
addit
serum
antibodi
could
improv
current
use
intramuscularli
inject
hepat
b
surfac
antigen
hbsag
produc
transgen
yeast
cell
mcaleer
et
al
two
type
hepat
b
vaccin
licens
us
food
drug
administr
fda
human
use
purifi
intramuscular
inject
first
base
hbsag
deriv
human
plasma
second
recombin
yeastderiv
hbsag
beyond
potenti
mucos
immun
oral
administ
plantderiv
vaccin
would
use
sever
reason
could
improv
success
rate
full
immun
vaccin
could
taken
without
requir
return
facil
provid
inject
would
heat
stabl
could
thu
reach
children
remot
area
would
requir
use
needl
pose
risk
infect
howev
light
increasingli
global
use
yeastderiv
hepat
b
vaccin
develop
develop
countri
plantderiv
vaccin
would
offer
distinct
advantag
interfer
effort
expand
vaccin
report
express
hbsag
tobacco
leaf
first
descript
plant
express
vaccin
immunogen
mason
et
al
recombin
tobacco
hbsag
recov
spheric
particl
averag
diamet
nm
similar
nativ
subvir
particl
blood
infect
human
similar
yeastderiv
vaccin
mcaleer
et
al
tobaccoderiv
hbsag
stimul
immun
respons
mice
vaccin
intraperiton
similar
produc
commerci
vaccin
includ
product
igg
subclass
igm
thanavala
et
al
addit
cell
mice
immun
plantderiv
hbsag
prolifer
respons
yeastderiv
hbsag
indic
fidel
tcell
epitop
plantproduc
protein
studi
follow
aim
improv
amount
antigen
produc
plant
system
optim
differ
construct
richter
et
al
sojikul
et
al
well
prove
oral
deliv
plant
materi
could
elicit
immun
respons
kong
et
al
construct
contain
unmodifi
hbsag
driven
constitut
camv
promot
termin
potato
pinii
polyadenyl
signal
yield
highest
express
hbsag
potato
tuber
richter
et
al
immunoelectron
microscopi
section
potato
leaf
show
spheric
filament
subvir
particl
assembl
vivo
accumul
endoplasm
reticulum
er
deriv
vesicl
mice
fed
week
week
g
raw
tuber
contain
averag
hbsagdos
compar
mice
gavag
purifi
yeast
recombin
hbsag
kong
et
al
either
case
ct
per
dose
given
mucos
adjuv
potatodeliv
hbsag
potent
immunogen
deliv
oral
primari
serum
igg
antibodi
respons
began
two
feed
transgen
potato
contain
total
hbsag
wherea
primari
immun
respons
detect
two
dose
yeastderiv
hbsag
contain
total
hbsag
author
suggest
differ
due
enhanc
stabil
antigen
retain
plant
cell
serum
igg
antibodi
level
potatoprim
mice
declin
week
rebound
dramat
high
last
titer
singl
intraperiton
inject
subimmunogen
dose
yeast
recombin
vaccin
furthermor
mice
prime
subimmunogen
intraperiton
dose
commerci
vaccin
fed
hbsag
potato
respond
longlast
secondari
antibodi
respons
antibodi
titer
decreas
time
remain
estim
protect
level
iul
month
challeng
experi
termin
kong
et
al
result
suggest
prime
singl
inject
follow
addit
dose
oral
deliv
plantderiv
vaccin
could
use
human
chang
immun
strategi
would
especi
use
develop
countri
inject
deliveri
multipl
dose
vaccin
signific
problem
massiv
immun
one
publish
report
immunogen
human
oral
deliv
hbsag
express
plant
kapusta
et
al
two
three
volunt
ate
two
dose
transgen
lettuc
contain
hbsag
per
dose
develop
modest
protect
iul
serum
antibodi
titer
second
dose
serum
antibodi
titer
declin
rapidli
week
probabl
low
dosag
howev
studi
show
presum
subject
could
seroconvert
oral
deliveri
plantexpress
hbsag
unit
state
other
direct
clinic
trial
roswel
park
cancer
institut
buffalo
ny
test
oral
immunogen
recombin
potato
express
hbsag
kong
et
al
sinc
chronic
hbv
infect
lead
liver
cancer
fda
concern
oral
deliveri
hbsag
could
caus
oral
toler
thu
studi
limit
volunt
previous
vaccin
seroconvert
standard
inject
hbsag
experi
involv
volunt
ate
either
two
day
three
day
dose
hbsag
potato
tuber
contain
mg
hbsag
per
dose
measur
auszym
monoclon
immunoassay
abbott
laboratori
abbott
park
il
group
volunt
ate
nontransgen
potato
potato
hbsag
vaccin
stimul
boost
serum
igg
antibodi
titer
half
volunt
thanavala
et
al
unpublish
result
suggest
oral
ingest
plantproduc
hbsag
could
viabl
deliveri
system
hbv
vaccin
rotaviru
common
form
diarrhea
estim
caus
approxim
death
annual
primarili
among
children
develop
countri
frequent
caus
childhood
diarrhearel
hospit
unit
state
group
rotaviru
gar
one
lead
caus
acut
infecti
viral
diarrhea
human
livestock
rotaviru
major
inner
capsid
protein
defin
protect
antigen
choi
et
al
constitut
weight
virion
protein
well
conserv
viru
serogroup
kapikian
et
al
addit
capsid
protein
nonstructur
protein
acid
peptid
function
viral
enterotoxin
also
identifi
induct
antibodi
amino
acid
peptid
alon
might
confer
protect
clinic
diseas
without
need
induct
antibodi
structur
protein
oneal
et
al
other
shown
elicit
protect
rotaviru
shed
mous
model
protect
attribut
cell
epitop
proteinthes
attribut
indic
protein
potenti
candid
subunit
vaccin
rotaviru
choi
et
al
other
report
express
bovin
group
rotaviru
transgen
potato
plant
occur
level
leaf
tuber
tissu
tsp
respect
matsumura
et
al
mice
vaccin
intraperiton
concentr
potato
tuber
extract
estim
contain
ng
result
antigar
antibodi
detect
western
blot
express
potato
tuber
boost
use
two
tandem
repeat
sequenc
camv
promot
untransl
region
tobacco
mosaic
viru
yield
tsp
tuber
increas
subsequ
experi
test
oral
immun
tuberproduc
adopt
differ
approach
other
use
fusion
protein
approach
acid
peptid
subunit
cholera
toxin
yu
langridg
group
report
express
potato
tuber
recombin
holotoxin
acid
immunodomin
murin
rotaviru
enterotoxin
cterminu
ctb
etec
bacteri
fimbrial
protein
fuse
nterminu
subunit
recombin
b
particl
assembl
holotoxinlik
molecul
mice
oral
immun
five
dose
tuber
tissu
contain
fusion
protein
per
dose
show
serum
mucos
antibodi
well
high
level
indic
immun
respons
offspr
born
dam
oral
immun
fusion
protein
partial
protect
challeng
live
murin
rotavirusth
success
multipl
fusion
protein
strategi
show
possibl
plantbas
multicompon
vaccin
sever
diarrheal
pathogen
swine
transmiss
gastroenter
tge
econom
import
herd
health
problem
global
highli
contagi
viral
diarrheal
diseas
neonat
pig
result
mortal
among
sever
case
saif
wesley
see
chapter
rapid
cours
diseas
immatur
immun
system
newborn
piglet
unabl
develop
protect
immun
depend
upon
presenc
siga
mother
milk
protect
viru
date
commerci
avail
vaccin
either
attenu
inactiv
unabl
adequ
protect
piglet
tuboli
et
al
swine
tge
caus
transmiss
gastroenter
viru
tgev
coronaviru
immunodomin
spike
protein
protein
induc
neutral
antibodi
viru
protect
immun
host
direct
toward
protein
contain
four
major
antigen
site
ntermin
region
jiminez
et
al
protein
express
mani
system
includ
baculoviru
tuboli
et
al
human
adenoviru
torr
et
al
other
report
express
tgev
protein
transgen
arabidopsi
thaliana
conveni
plant
model
system
gomez
et
al
level
protein
obtain
leav
tsp
immun
mice
intramuscularli
crude
plant
extract
induc
tgevspecif
antibodi
virusneutr
index
comparison
index
rabbit
sera
antitgev
antibodi
use
posit
control
protein
express
tobacco
leav
tsp
tuboli
et
al
transgen
leaf
extract
given
intraperiton
pig
stimul
tgevspecif
serum
antibodi
low
level
virusneutr
activ
studi
ntermin
domain
protein
codonoptim
tobacco
cell
result
express
level
time
higher
obtain
previous
gomez
et
al
data
mucos
immun
describ
either
studi
report
howev
result
indic
plantexpress
protein
present
virusneutr
epitop
thu
compet
immunogen
perhap
promis
studi
show
protect
mucos
deliv
plantbas
vaccin
involv
tgev
protein
express
corn
lamphear
et
al
group
report
oral
immun
specificpathogenfre
tgevseroneg
piglet
transgen
corn
meal
express
protein
test
anim
fed
nontransgen
corn
mix
g
transgen
corn
contain
mg
protein
medic
milk
replac
daili
period
control
group
oral
immun
either
commerci
modifi
live
vaccin
nontransgen
corn
piglet
oral
challeng
virul
form
viru
clinic
symptom
evaluatedwhil
pig
vaccin
transgen
corn
develop
diarrhea
group
immun
commerci
avail
vaccin
fed
nontransgen
corn
becam
ill
observ
suggest
cornderiv
protein
gener
immun
respons
adequ
confer
partial
protect
viru
specif
antibodi
assay
report
studi
howev
anim
vaccin
commerci
vaccin
appear
recov
much
faster
observ
suggest
commerci
vaccin
gener
stronger
cytotox
tcell
ctl
respons
boost
infect
subsequ
experi
lamphear
et
al
piglet
oral
immun
cornexpress
protein
memori
immun
respons
lead
rapid
accumul
virusneutr
antibodi
oral
immun
piglet
expos
enough
tgev
caus
subclin
infect
studi
differ
dosag
regimen
consecut
day
protein
corn
commerci
vaccin
show
anim
protein
corn
regimen
morbid
anim
fed
nontransgen
corn
display
symptom
anim
fed
transgen
corn
dosag
regimen
show
morbid
respect
indic
dosag
regimen
effect
protect
pig
frequenc
dosag
therefor
critic
vaccin
group
immun
commerci
vaccin
morbid
rate
comparison
zero
cornderivedvaccin
recipi
dosag
regimen
result
suggest
cornderiv
protein
margin
effect
howev
work
explor
viru
challeng
titer
relev
field
rather
enough
caus
subclin
infect
effort
indic
feasibl
produc
plantbas
tgev
vaccin
transgen
plant
work
cornderiv
protein
especi
interest
corn
main
constitu
livestock
diet
requir
extens
heat
process
furthermor
stabil
antigen
corn
kernel
matrix
establish
dosag
size
mg
protein
g
corn
meal
indic
reason
express
level
attain
antigen
maiz
footandmouth
diseas
viru
fmdv
consid
econom
import
veterinari
pathogen
highli
infecti
natur
abil
caus
persist
infect
longterm
effect
condit
product
mani
anim
speci
affect
countri
fmdv
infect
activ
face
mani
trade
restrict
knowl
samuel
outbreak
diseas
occur
formal
quarantin
approach
gener
employ
contain
diseas
vaccin
suscept
host
inactiv
viru
viabl
strategi
control
diseas
use
countri
expens
difficulti
distinguish
immun
infect
anim
fmd
caus
sever
strain
viru
belong
genu
aphthoviru
picornavirida
famili
critic
epitop
result
induct
neutral
antibodi
identifi
structur
protein
fmdv
brown
one
group
report
express
fmdv
transgen
thaliana
plant
carillo
et
al
studi
balbc
mice
immun
intraperiton
plant
extract
incomplet
freund
adjuv
stimul
serum
antibodi
react
strongli
intact
fmdv
particl
mice
challeng
intraperiton
virul
viru
protect
determin
absenc
viremia
hour
postinocul
control
group
protect
other
report
express
protein
transgen
alfalfa
studi
mice
fed
g
transgen
leav
fortnightli
basi
three
dose
mg
total
solubl
protein
develop
virusneutr
antibodi
anim
protect
intraperiton
challeng
wigdorovitz
et
al
common
problem
fmdv
studi
low
level
express
protein
result
limit
immunogen
exampl
one
group
develop
methodolog
rapidli
screen
transgen
express
level
larg
number
transgen
plant
independ
transgen
event
du
santo
et
al
methodolog
involv
fusion
fmdv
peptid
readili
assay
gu
report
gene
yield
high
correl
express
gu
epitop
fuse
tsp
mice
immun
intraperiton
crude
extract
select
transgen
plant
readili
develop
strong
complet
protect
immun
respons
observ
level
express
peptid
vaccin
result
higher
antibodi
titer
previous
report
full
protein
express
alfalfa
carillo
et
al
rabi
viral
diseas
mammal
commonli
transmit
bite
rabid
anim
diseas
unusu
affect
human
wildlif
domest
anim
readili
transmit
anim
human
unit
state
rabi
case
report
center
diseas
control
prevent
year
occur
wild
anim
raccoon
skunk
bat
fox
less
report
occur
domest
anim
cat
cattl
dog
howev
rabi
remain
major
threat
human
world
today
fatal
case
report
year
plotkin
global
estim
million
peopl
receiv
postexposur
antiserum
treatment
year
expos
rabiessuspect
anim
fact
sheet
number
modern
vaccin
human
expens
especi
dens
popul
countri
africa
asia
rabi
endem
remain
major
health
problem
exampl
report
india
individu
expos
rabi
receiv
primit
brain
tissu
vaccin
safer
efficaci
modern
product
unafford
koprowski
yusibov
rabi
viru
infect
central
nervou
system
caus
encephalopathi
inevit
death
rabi
viru
glycoprotein
g
protein
major
viral
protein
respons
induct
protect
immun
respons
nucleoprotein
n
protein
trigger
cell
respons
facilit
product
neutral
antibodi
immun
function
tolli
et
al
oral
vaccin
baculovirusexpress
g
protein
shown
protect
raccoon
lethal
challeng
viru
boost
n
protein
enhanc
protect
immun
respons
fu
et
al
plantbas
edibl
rabi
vaccin
low
cost
oral
administ
would
use
preexposur
vaccin
children
older
person
develop
countri
rabi
highli
endem
report
product
transgen
tomato
fruit
rabi
viru
g
protein
estim
tsp
mcgarvey
et
al
howev
immun
studi
describ
protein
group
observ
tomatosynthes
g
protein
smaller
mammalian
protein
yet
larger
predict
size
unglycosyl
protein
indic
plant
glycosyl
occur
perhap
absenc
sialic
acid
plant
glycan
result
observ
smaller
molecul
size
chimer
plant
virus
use
express
immunogen
rabi
viru
g
protein
bcell
epitop
tcell
epitop
n
protein
yusibov
et
al
work
suggest
optim
transgen
plant
express
could
produc
viabl
rabi
vaccin
poultri
industri
signific
compon
global
agricultur
success
depend
abil
maintain
healthi
bird
vaccin
one
key
strategi
diseas
manag
mani
case
bird
immun
attenu
live
vaccin
use
edibl
vaccin
poultri
industri
result
signific
cost
save
greatli
simplifi
current
vaccin
strategi
avoid
practic
immun
via
live
vaccin
infecti
bursal
diseas
viru
ibdv
global
import
poultri
pathogen
major
antigen
viru
structur
protein
one
group
current
work
usdafund
project
product
recombin
protein
transgen
plant
scissumgunn
alabama
state
univers
colleagu
work
oral
immun
boost
unvaccin
chick
challeng
ibdv
serum
bursal
tissu
examin
plan
preliminari
result
follow
oral
vaccin
recombin
express
transgen
thaliana
encourag
futur
express
alfalfa
plan
k
scissumgunn
person
commun
base
upon
result
present
chapter
clear
plantbas
vaccin
hold
great
promis
like
form
integr
part
futur
arsen
antigen
product
system
vaccin
transgen
plantderiv
vaccin
antigen
shown
oral
immunogen
human
sever
anim
speci
partial
protect
pathogen
challeng
shown
tgev
fmdv
mice
sever
issu
remain
address
includ
potenti
risk
factor
associ
product
pharmaceut
transgen
plant
first
progress
need
made
improv
yield
antigen
ensur
uniform
yield
enhanc
immunogen
oral
administ
vaccin
assess
potenti
develop
immun
toler
second
sever
regulatori
issu
materi
produc
field
interact
biotic
abiot
factor
environ
could
affect
express
stabil
potenti
compromis
integr
product
thu
import
ensur
suffici
analysi
plantderiv
product
valid
uniform
function
potenti
risk
environ
associ
public
percept
risk
must
care
consid
end
usda
recent
propos
strict
measur
minim
environment
risk
includ
physic
contain
rigor
regul
transport
process
dispos
plantmad
pharmaceut
biolog
contain
practic
minim
unintent
releas
includ
use
male
steril
line
minim
transgen
escap
via
pollen
tissu
organspecif
express
recombin
protein
choic
crop
product
vaccin
direct
bear
abil
contain
transgen
pollenshed
crop
present
greater
challeng
like
tomato
selfpollin
speci
strategi
monitor
gene
within
environ
employ
use
domin
marker
gene
highresolut
detect
system
effici
product
process
monitor
system
final
activ
particip
plant
biotechnolog
industri
import
step
develop
plantbas
vaccin
dow
agrosci
llc
da
indianapoli
invest
substanti
effort
toward
develop
plantderiv
vaccin
anim
butch
mercer
da
person
commun
result
dassupport
studi
encourag
may
lead
commerci
excit
new
technolog
